Collexis Unveils Enhanced Services for Premier Online Scientific Social Network Community, BioMedExperts.

Innovative Online Resource Enables Increased Global Collaboration Among Researchers and Helps Advance Medical Science

COLUMBIA, S.C. -- Collexis Holdings, Inc. (OTCBB:CLXS), announced today website enhancements to BioMedExperts.com, the first online social network of its kind that promotes global collaborative medical research and development.

Collexis launched BioMedExperts.com in January 2008 to facilitate collaboration and increase biomedical research among health care and life sciences professionals. With 1.4 million pre-generated researcher profiles with pre-established network connections from more than 120 countries, BioMedExperts.com is a revolutionary online tool that enables users to connect with each other - free of charge - through the display and analysis of the networks of co-authors with whom each investigator works to publish scientific papers.

The initiative is the result of an agreement in which Collexis developed the knowledge discovery solutions and text mining applications for BioMedExperts and Dell Healthcare and Life Sciences provided the hardware and continued marketing support for the site. To help BioMedExperts.com users explore and expand their scientific networks, Collexis have added several new features to the site, including:

* Expansion of available publication data back to 1980 (from 1996 in Version 1.0)

* Four million new connections, bringing the total to more than 21 million connections

* A new directory of more than 1,800 organizations and institutions from 137 countries

* Public profiles - Non-registered users will have access to 1.4 million basic profiles

* Improved features to identify and invite colleagues in your network

"The goal of BioMedExperts is to bring together researchers from all around the world so that they may collaborate and connect with one another from one central location. To help further this process, we are unveiling a series of enhancements that are designed to allow researchers to more easily connect with one another and, at the same time, invite their colleagues to take advantage of this innovative resource," said Bill Kirkland, CEO of Collexis Holdings, Inc. "By allowing scientific researchers to quickly and easily connect with and expand their global professional network, we're confident the BioMedExperts.com site will help foster a greater advancement in biomedical research and ultimately benefit us all."

Additional enhancements are planned over the next three months so that users may continue to grow their professional networks, identify researchers with necessary expertise for future collaboration and analyze the profiles and published research of scientists across the globe.

About Collexis Holdings, Inc.

Collexis Holdings, Inc., a leading developer of high definition search and knowledge discovery software since 1999, is headquartered in Columbia, South Carolina (USA) with operations in Cincinnati, Ohio, Geldermalsen, the Netherlands and Cologne, Germany. Collexis now offers the world's first pre-populated professional social network for life science researchers, www.biomedexperts.com. Collexis' proprietary technology builds conceptual profiles of text, called Fingerprints, from documents, Websites, emails and other digitized content and matches them with a comprehensive list of pre-defined "fingerprinted" concepts to make research results more relevant and efficient. This matching of concepts eliminates the ambiguity and lack of priority associated with word searches. The results are often described as "finding needles in many haystacks." Through this novel approach, Collexis can build unique applications to search, index and aggregate information as well as prioritize, trend and predict data based on sources in multiple industries without the limitations of language or dialect. Collexis' current clients in the public, private and academic sectors include the Mayo Clinic; Johns Hopkins University; the University of California, San Francisco; the University of South Carolina; Erasmus University Library; Bristol-Myers Squibb; Lockheed Martin; the World Health Organization; Wellcome Trust; the National Institutes of Health; and the U.S. Department of Defense. Shares of Collexis common stock are traded under the symbol CLXS on the OTC Bulletin Board (OTC BB). For more information, visit www.collexis.com.

Forward-Looking Statements

Some of the statements made in this press release may constitute forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. These forward-looking statements are based on management's current expectations and include known and unknown risks, uncertainties and other factors, many of which the company is unable to predict or control, that may cause the company's actual results or performance to differ materially from any future results or performance expressed or implied by such forward-looking statements. These statements involve risks and uncertainties, including risks and uncertainties associated with the development and enhancement of services provided through the BioMedExperts.com website. These risks and uncertainties are in addition to other factors detailed from time to time in the company's filings with the SEC, including the section entitled "Risk Factors" in its transition report on Form 10-KSB for the period ended June 30, 2007, as amended. The company cautions investors that any forward-looking statements made by the company are not necessarily indicative of future performance. The company is not responsible for updating the information contained in this press release beyond the published date, or for changes made to this document by wire services or Internet services.